HERSHBERG ROBERT
CIK 1274139
Transactions on file
16
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-10-06 | RXRX RECURSION PHARMACEUTICALS, INC. | Director | Sale | 25,000 | $125.0K | -28.4% | open → |
| 2026-10-07 | 2026-10-06 | RXRX RECURSION PHARMACEUTICALS, INC. | Director | Exer. | 25,000 | $55.5K | +61.3% | open → |
| 2026-08-21 | 2026-08-18 | ADPT Adaptive Biotechnologies Corp | Director | Sale | 15,664 | $382.4K | +0.0% | open → |
| 2026-08-21 | 2026-08-18 | ADPT Adaptive Biotechnologies Corp | Director | Sale | 15,000 | $365.9K | +0.1% | open → |
| 2026-08-21 | 2026-08-18 | ADPT Adaptive Biotechnologies Corp | Director | Exer. | 15,000 | $94.8K | +286.2% | open → |
| 2026-07-09 | 2026-07-07 | ATAI AtaiBeckley Inc. | Sale | 100,000 | $496.0K | +44.8% | open → | |
| 2026-07-09 | 2026-07-07 | ATAI AtaiBeckley Inc. | Exer. | 51,142 | $69.0K | +431.9% | open → | |
| 2026-07-09 | 2026-07-07 | ATAI AtaiBeckley Inc. | Exer. | 48,858 | $66.0K | +431.9% | open → | |
| 2026-06-22 | 2026-06-17 | RXRX RECURSION PHARMACEUTICALS, INC. | Director | Grant | 88,424 | $0.00 | — | open → |
| 2025-02-12 | 2025-02-04 | HLVX HilleVax, Inc. | OfficerDirector See Remarks | Sale | 14,634 | $27.7K | — | open → |
| 2025-02-12 | 2025-02-11 | HLVX HilleVax, Inc. | OfficerDirector See Remarks | Sale | 11,901 | $20.9K | — | open → |
| 2025-03-06 | 2025-03-04 | ADPT Adaptive Biotechnologies Corp | Director | Grant | 15,394 | $0.00 | — | open → |
| 2025-03-12 | 2025-03-12 | ADPT Adaptive Biotechnologies Corp | Director | Sale | 53,000 | $402.3K | +221.6% | open → |
| 2025-06-23 | 2025-06-18 | RXRX RECURSION PHARMACEUTICALS, INC. | Director | Grant | 22,016 | $0.00 | — | open → |
| 2025-12-12 | 2025-12-10 | ADPT Adaptive Biotechnologies Corp | Director | Sale | 22,968 | $367.5K | +52.6% | open → |
| 2025-09-17 | 2025-09-17 | HLVX HilleVax, Inc. | OfficerDirector President and CEO | U | 1,101,498 | — | — | open → |
